I speculate that BMY has yet to find the combination therapy from other partners to raise RRRs it needs to produce increased use of either Yervoy or Opdivo that the street once thought it would achieve.
am surprised to see bmy still down here at this level. 55 seems to be good support, but if it breaks we see 50 next. I shall wait to get back into this one.